Healthcare Global Enterprises Limited — Important, 13-11-2025: Updates
13-11-2025 | 04:25 pm
13-11-2025 | 04:25 pm
Company's board approved Q2FY26 results. Consolidated revenue rose to 645.16 Cr, profit at 20.66 Cr. Standalone profit was 10.78 Cr. Key developments include a 7 Cr investment in Cancer Care Kenya and a 9.60 Cr deferred tax credit. An open offer acquired 318 shares at Rs. 504.41.
No comments yet. Be the first to comment!
All announcements from Healthcare Global Enterprises Limited
